Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BYScientific Reports

Predictive value of systemic inflammatory indices in metabolic syndrome and non-alcoholic fatty liver disease in Iran

5 affiliations
  1. 1Leishmaniasis Research Center, Sabzevar University of Medical Sciences
  2. 2Department of Pediatrics, School of Medicine, Sabzevar University of Medical Sciences
  3. 3Student Research Committee, Sabzevar University of Medical Sciences
  4. 4Faculty of Pharmacy, Mashhad University of Medical Sciences
  5. 5Non-Communicable Diseases Research Center, Sabzevar University of Medical Sciences

Abstract

The prevalence of metabolic syndrome has increased significantly, and visceral obesity is closely associated with non-alcoholic fatty liver disease. This study aimed to investigate the association between inflammatory indices derived from blood cell counts and to investigate the association between inflammatory indices, metabolic syndrome, and NAFLD in Sabzevar, Iran, in 2025. This case–control study used data from a large adult cohort. A total of 1500 participants with metabolic syndrome were selected as the case group, and for each case, one control without metabolic syndrome was randomly selected from the same cohort. All participants were subsequently evaluated for the presence or absence of non-alcoholic fatty liver disease and, additionally, for liver fibrosis using the Fibrosis-4 (FIB-4) index. Data were analyzed using SPSS version 16, and a p-value < 0.05 was considered statistically significant. In this study, the mean age was 51.01 ± 8.3 years in the metabolic syndrome group and 46.9 ± 8.2 years in the healthy group. In the metabolic syndrome group, 621 participants were male and 879 were female. Overall, no significant associations were observed between metabolic syndrome and inflammatory indices, including the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammatory response index, hemoglobin level, or liver fibrosis classification based on the Fibrosis-4 (FIB-4) index. In contrast, metabolic syndrome was significantly associated with demographic factors, anthropometric measures, metabolic parameters, non-alcoholic fatty liver disease, and the monocyte-to–high-density lipoprotein cholesterol ratio. Non-alcoholic fatty liver disease showed no significant association with the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, hemoglobin level, or systemic inflammatory response index. Still, it was significantly associated with demographic characteristics, anthropometric indices, metabolic factors, the platelet-to-lymphocyte ratio, systemic immune-inflammation index. Liver fibrosis classification based on the FIB-4 index was not significantly associated with several metabolic and inflammatory variables; however, it showed significant associations with age, sex, anthropometric measures, selected inflammatory indices, and hemoglobin level. Given that imaging methods are costly and not readily accessible for all patients, the findings of this study may provide a basis for identifying more cost-effective and easily accessible approaches for the diagnosis of this disease.

Related

  1. Triglyceride-Glucose Index and Systemic Inflammatory Markers in Polyendocrine Metabolic Ovarian Syndrome (Polycystic Ovary Syndrome): A Cross-Sectional Study
    Meryem Kececi Oguzhanoglu, Kursat Oguzhanoglu
    MetabolitesPeer-reviewedCC BY 4.0Obstetrics, gynaecology & paediatricsCrossref
  2. Beyond BMI: Associations of Body-Shape Indices with CBC-Derived Systemic Inflammatory Indices in Adults with Metabolic Syndrome: A Cross-Sectional Study
    Kamil Konur, Erol Karavar, Oğuzhan Kesen +2
    MetabolitesPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  3. Machine learning based predictive model for cardiovascular disease mortality risk in patients with stage 4 cardiovascular–kidney–metabolic syndrome
    Pengyu Zhang, Sining Wang, He Yang +6
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Blood Cytokine Profiling Reveals Distinct Inflammatory Signatures in Phenotypes A and B of Polyendocrine Metabolic Ovarian Syndrome (PMOS; formerly PCOS).
    L. P. Patra, B. S. Johnson, K. P. Jayakrishnan +2
    medRxivPreprintAll rights reservedFull textEndocrinology & metabolismmedRxiv
  5. Is There a Correlation Between Inflammatory Markers and Anti-Müllerian Hormone Level in Non-Obese Patients with Polyendocrine Metabolic Ovarian Syndrome?
    Dominika Gałczyńska, Natalia Przybyła, Kinga Wołkowska +4
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{neamatshahi2026predictive,
  title = {{Predictive value of systemic inflammatory indices in metabolic syndrome and non-alcoholic fatty liver disease in Iran}},
  author = {Mahboubeh Neamatshahi and Aghil Keykhosravi and Maryam Jahandoost Erdizi and Ali Keykhosravi and Zeinab Jalambadani},
  journal = {Scientific Reports},
  year = {2026},
  month = jul,
  doi = {10.1038/s41598-026-63141-7},
  url = {https://doi.org/10.1038/s41598-026-63141-7},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Predictive value of systemic inflammatory indices in metabolic syndrome and non-alcoholic fatty liver disease in Iran
AU  - Mahboubeh Neamatshahi
AU  - Aghil Keykhosravi
AU  - Maryam Jahandoost Erdizi
AU  - Ali Keykhosravi
AU  - Zeinab Jalambadani
PY  - 2026
DA  - 2026/07/01
JO  - Scientific Reports
DO  - 10.1038/s41598-026-63141-7
UR  - https://doi.org/10.1038/s41598-026-63141-7
AB  - The prevalence of metabolic syndrome has increased significantly, and visceral obesity is closely associated with non-alcoholic fatty liver disease. This study aimed to investigate the association between inflammatory indices derived from blood cell counts and to investigate the association between inflammatory indices, metabolic syndrome, and NAFLD in Sabzevar, Iran, in 2025. This case–control study used data from a large adult cohort. A total of 1500 participants with metabolic syndrome were selected as the case group, and for each case, one control without metabolic syndrome was randomly selected from the same cohort. All participants were subsequently evaluated for the presence or absence of non-alcoholic fatty liver disease and, additionally, for liver fibrosis using the Fibrosis-4 (FIB-4) index. Data were analyzed using SPSS version 16, and a p-value < 0.05 was considered statistically significant. In this study, the mean age was 51.01 ± 8.3 years in the metabolic syndrome group and 46.9 ± 8.2 years in the healthy group. In the metabolic syndrome group, 621 participants were male and 879 were female. Overall, no significant associations were observed between metabolic syndrome and inflammatory indices, including the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammatory response index, hemoglobin level, or liver fibrosis classification based on the Fibrosis-4 (FIB-4) index. In contrast, metabolic syndrome was significantly associated with demographic factors, anthropometric measures, metabolic parameters, non-alcoholic fatty liver disease, and the monocyte-to–high-density lipoprotein cholesterol ratio. Non-alcoholic fatty liver disease showed no significant association with the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, hemoglobin level, or systemic inflammatory response index. Still, it was significantly associated with demographic characteristics, anthropometric indices, metabolic factors, the platelet-to-lymphocyte ratio, systemic immune-inflammation index. Liver fibrosis classification based on the FIB-4 index was not significantly associated with several metabolic and inflammatory variables; however, it showed significant associations with age, sex, anthropometric measures, selected inflammatory indices, and hemoglobin level. Given that imaging methods are costly and not readily accessible for all patients, the findings of this study may provide a basis for identifying more cost-effective and easily accessible approaches for the diagnosis of this disease.
SN  - 2045-2322
ER  -